Research Article

Prognostic Value of Cancer Stem Cells Markers in Triple-Negative Breast Cancer

Table 2

Relation between CD24, ALD1A1, and ABCG2 with clinical pathological features in TNBC patients.

CD24 valueALDH valueABCG2 value
LowHighLow HighNegativeLowHigh

Age
 <401 (5,6%)17 (94,4%)13 (68,4%)6 (28,6%)2 (11,1%)7 (38,9%)9 (50%)
 >40 ≤ 607 (12,3%)50 (87,7%)0,70639 (65%)21 (35%)0,5599 (15,8%)8 (14%)40 (70,2%)0,132
 >606 (9,8%)55 (90,2%)48 (73,8%)17 (26,2%)15 (23%)12 (18,5%)38 (58,5%)
 Missed data0101001
Histotype
 IDC9 (8%)104 (92%)85 (70,8%)35 (29,2%)23 (19,5%)21 (17,8%)74 (62,7%)
 NIDC5 (20,8%)19 (79,2%)0,05915 (60%)10 (40%)0,4273 (13%)6 (26%)14 (61%)0,567
 Missed data0000000
Size
 ≤2 cm4 (6,6%)57 (93,4%)43 (67,2%)21 (32,8%)14 (21,5%)12 (18,5%)39 (60%)
 >2 ≤ 59 (14,8%)52 (85,2%)0,31446 (69,7%)20 (30,3%)0,94610 (16,1%)10 (16,1%)42 (67,8%)0,599
 >51 (7,7%)12 (92,3%)8 (66,6%)4 (33,4%)2 (16,6%)4 (33,4%)6 (50%)
 Missed data0230011
LNM
 Negative8 (10,4%)69 (89,6%)58 (74,4%)20 (25,6%)13 (17,3%)15 (20%)47 (62,7%)
 Positive6 (11,1%)48 (88,9%)0,89538 (62,3%)23 (37,7%)0,12713 (21,6%)10 (16,7%)37 (61,7%)0,767
 Missed data0642024
Metastasis
 Negative11 (10,4%)95 (89,6%)80 (70,2%)34 (29,8%)20 (18,5%)21 (19,4%)67 (62%)
 Positive3 (9,7%)28 (90,3%)0,91020 (64,5%)11 (35,5%)0,5466 (18,2%)6 (18,2%)21 (63,6%)0,982
 Missed data0000000
Grading
 G10 (0%)2 (100%)1 (100%)0 (0%)0 (0%)1 (100%)0 (0%)
 G21 (9%)10 (91%)0,8757 (53,8%)6 (46,2%)0,3864 (36,4%)2 (18,2%)5 (45,4%)0,145
 G313 (10,7%)108 (89,3%)89 (70,1%)38 (29,9%)22 (17,5%)23 (18,2%)81 (64,3%)
 Missed data0331012
Ki67
 ≤20%2 (8,3%)22 (91,7%)21 (91,3%)3 (8,7%)8 (32%)7 (28%)10 (40%)
 >20%9 (8,5%)97 (91,5%)0,98076 (66,7%)38 (33,3%)0,04216 (14,4%)19 (17,1%)76 (68,5%)0,024
 Missed data3434212

IDC = infiltrant ductal carcinoma; NIDC = noninfiltrant ductal carcinoma; LNM = lymph node metastasis.